Neofuragina Max (Furazidine)

Furazidine, the active ingredient in Neofuragina Max, is a nitrofuran antibiotic presented as an oral tablet for oral use. It treats urinary tract infections in adult patients and is prescribed when the causative bacteria are susceptible.

GNH USA supplies Neofuragina Max as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Furazidine is a nitrofuran antibiotic used to manage bacterial infections of the urinary tract.

- Uncomplicated urinary tract infection: eradicates susceptible uropathogens and relieves symptoms such as dysuria and frequency. - Complicated urinary tract infection: provides antibacterial coverage when standard agents are ineffective. - Recurrent urinary infection prophylaxis: may be employed to reduce the frequency of repeat infections in patients with a documented history of susceptibility.

Adverse reactions to Furazidine may range from mild to severe. Monitoring for any new symptoms during therapy is recommended.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Vomiting: occasional emesis. - Diarrhea: loose stools. - Abdominal pain: cramping discomfort. - Headache: transient head pain. - Rash: mild skin erythema.

Serious or Rare Side Effects: - Severe allergic reaction: anaphylaxis, swelling of face or throat. - Hepatic dysfunction: jaundice or elevated liver enzymes. - Hematologic abnormalities: agranulocytosis, thrombocytopenia. - Stevens‑Johnson syndrome: severe skin blistering. - Hemolytic anemia: rapid drop in red blood cells. - Renal impairment: acute kidney injury.

Before initiating Furazidine therapy, consider patient‑specific factors and monitor for potential complications. - Assess renal function: adjust use if creatinine clearance is reduced. - Monitor liver enzymes: discontinue if significant hepatic injury occurs. - Avoid in known hypersensitivity: discontinue at first sign of allergic reaction. - Use with caution in pregnancy: limited data, weigh benefits against risks. - Review concomitant anticoagulant therapy: monitor coagulation parameters. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Furazidine can affect the activity of several co‑administered medicines; awareness of interaction severity helps guide clinical decisions.

Major Interactions (Avoid): - Warfarin: increased anticoagulant effect, risk of bleeding. - Methotrexate: heightened toxicity, especially renal impairment. - Live vaccines: possible reduction in vaccine efficacy.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may reduce hormonal effectiveness. - Diuretics: potential electrolyte disturbances. - Allopurinol: increased risk of skin rash. - Antacids containing aluminum or magnesium: may decrease Furazidine absorption.